1/ There's good evidence that to protect against severe disease, hospitalization, & death, the following would benefit from an additional dose of COVID vaccine:
- immunocompromised persons
- people 60-65+ (? 40+)
- residents of long-term care facilities

nytimes.com/2021/10/25/hea…
2/
3/ What should our goal be with the vaccines?
- Prevention of severe disease, hospitalization, & death
- Prevention of symptomatic infection (which means trying to prevent ALL infections since we can't always predict who'll be symptomatic)
4/ The current vaccines don't provide sterilizing immunity, so we won't be able to prevent ALL infections.

But even if want to prevent MOST infections, what would that take?
5/ It helps to acknowledge what the vaccines can & can't do (which I think many still don't understand):

theatlantic.com/ideas/archive/…

newyorker.com/news/q-and-a/w…

theatlantic.com/science/archiv…
6/ If we want to prevent ALMOST ALL infections, we'll need to consider:
- frequent (yearly?) COVID vaccine boosters
- complementing injectable COVID vaccines with mucosal COVID vaccines
- layering additional protections: masking, testing, ventilation, air filtration

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Céline Gounder, MD, ScM, FIDSA

Céline Gounder, MD, ScM, FIDSA Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @celinegounder

25 Oct
1/ Important new research by @KizzyPhD & other @NIAIDNews scientists on the Moderna vaccine in non-human primates.

They gave the primates 2 doses of the Moderna vaccine 4 weeks apart.

And challenged them with Delta variant virus 1 year later.

biorxiv.org/content/10.110…
2/
Gray: unvaccinated
Red: vaccinated

After vaccination, binding antibody levels:
- peaked at 6 weeks
- dropped weeks 6-25
- rate of decline slowed weeks 25-48
3/
Serum neutralizing antibody titers:
- dropped weeks 6-24
- rate of decline slowed weeks 24-48
- were highest vs D614G (early variant)⚫️>Gamma🟢>Beta🔴>Delta🔵
Read 28 tweets
24 Oct
1/ Why can't we just test people to see if they have immunity to SARS-CoV-2 and decide whether they need to be vaccinated based on that test result?

jamanetwork.com/journals/jama/…
2/ Commercially available tests (what you'd get through your doc's office / urgent care clinic) measure binding, not neutralizing antibodies.

While there is a correlation, it's an imperfect one.

We don't know what level of neutralizing antibodies are necessary for protection.
3/ Some tests only pick up antibodies after infection (e.g. antibodies to nucleocapside protein).

Others pick up antibodies after infection or vaccination (e.g. antibodies to spike protein).
Read 7 tweets
22 Oct
1/ Important reporting by @snolen for @nytimes today:
nytimes.com/interactive/20…

We keep being told: "Yes, we know. It's not right. It's a really hard problem. We're doing everything we can."

No, that's not Facebook on disinformation (well, that too).

That's the USG & Moderna.
2/ It makes no sense when you want to maintain control over the technology.

You could TRAIN people how to make mRNA vaccines.
3/ Thanks to @DrTomFrieden, @Public_Citizen, @PrEP4AllNow, & @MSF_USA for beating the drum on this:
Read 25 tweets
22 Oct
1/ On mixing & matching COVID shots, by @KatherineJWu in @TheAtlantic:
theatlantic.com/health/archive…

If you're eligible for an additional dose of COVID vaccine, you can get whichever you want (Pfizer, Moderna, or J&J).
2/ There were only ~50 people in each 9-arm of the NIH mix & match study for a total of less than 500.

Moderna was given full-dose (100 mcg) in the NIH mix & match study, not half-dose (50 mcg) as approved for boosters.
Higher dose➡️more side-effects

Read 5 tweets
21 Oct
1/ Some interesting slides from today's @CDCgov ACIP meeting:
cdc.gov/vaccines/acip/…

Waning immunity?
Or the Delta factor (more infectious, somewhat more immune-evading)?

Some of both.
But in 65+, it's the Delta factor.
2/ Also, those 65+ have a weaker immune response up front.

I'd expect to see the same among immunocompromised persons.

Immunosenescence is a form of immunocompromise.
3/ Why is there ⬇️VE vs hospitalization over time among those among 18-44 yo with 1+ non-immunocompromising chronic conditions?

Confounding by behavior?

If real, this would justify different eligibility criteria by race based on "weathering" argument:
washingtonpost.com/opinions/black…
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(